Ipamorelin 5 mg — Research Consultation
Ipamorelin is a synthetic pentapeptide growth-hormone-releasing peptide (GHRP) that acts as a selective ghrelin-receptor agonist. Published research describes selectivity for growth-hormone release without the cortisol or prolactin signals associated with earlier GHRP molecules. This page summarises the mechanism and links you into a Nour-led research consultation.
What ipamorelin is
Ipamorelin is a synthetic five-amino-acid peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) developed as a selective agonist of the growth-hormone-secretagogue receptor (GHSR-1a), the receptor for the endogenous hormone ghrelin. The published research literature highlights its selectivity profile relative to earlier GHRPs.
What the published literature covers
Animal-research and early-phase human studies describe pulsatile growth-hormone release, dose-dependent GH peak amplitude, and minimal effects on ACTH/cortisol or prolactin secretion in published reports. Ipamorelin is frequently paired in protocols with a GHRH analogue such as CJC-1295 to study combined GHRH + GHRP signalling, a paradigm well-documented in the published GH-secretion research.
Quality verification
Lyophilised ipamorelin manufactured under ICH Q7 GMP standards, with independent HPLC verification at a US-based third-party laboratory. Peak-area purity ≥98% against pharmacopoeia reference standards. Each released batch ships with a Certificate of Analysis available through the in-chat consultation.
Common research questions
- Is ipamorelin legal in the UAE?
- Ipamorelin is classified as a research compound in the UAE and is sold through standard wellness-supply channels with VAT compliance applied to every dispatch.
- What dose ranges does the published research describe?
- Published human pharmacology studies have used 1-100 mcg/kg single doses. In the grey-research community, protocols of 200-300 mcg administered subcutaneously two-to-three times daily are common, often paired with a GHRH analogue. No consensus optimal protocol exists.
- Ipamorelin vs. other GHRPs?
- The published literature characterises ipamorelin as more selective than GHRP-2 or GHRP-6 — fewer reported effects on ACTH/cortisol/prolactin in early-phase studies. This selectivity is the reason ipamorelin is the most-studied GHRP in current research protocols.
- Why pair with CJC-1295?
- GHRH analogues (like CJC-1295) and GHRPs (like ipamorelin) act on different receptors and produce additive GH release in published research. The paired protocol is the standard combined-signalling research model. Wellness Labs also stocks the CJC-1295 + ipamorelin blend for researchers studying the paired paradigm.
- How is purity verified?
- HPLC peak-area purity (≥98%) at a US-based third-party laboratory, against pharmacopoeia reference standards. COA available through the chat.
- Shelf life and storage?
- Lyophilised powder is ambient-temperature stable in transit; -20°C long-term storage; refrigerated post-reconstitution per the supplied protocol.
- How fast is delivery in the UAE?
- Same-day delivery within Dubai, next-business-day across the rest of the UAE.
Peer-reviewed references
Related consultations
Further reading
Talk to Nour about your research protocol
Nour reads the peer-reviewed literature and walks you through what each compound is best suited for. English or Arabic, inside the chat.